Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs).

Grozinsky-Glasberg, Simona; Lines, Kate E; Avniel-Polak, Shani; Bountra, Chas; Thakker, Rajesh V

Grozinsky-Glasberg, Simona; Lines, Kate E; Avniel-Polak, Shani; Bountra, Chas; Thakker, Rajesh V.

Afiliación

Grozinsky-Glasberg S; Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Lines KE; Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Avniel-Polak S; Neuroendocrine Tumor Unit, ENETS Center of Excellence, Department of Endocrinology and Metabolism, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Bountra C; Structural Genomics Consortium, University of Oxford, Oxford, UK.
Thakker RV; Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Churchill Hospital, Oxford, UK.

Endocr Relat Cancer ; 27(9): R345-R355, 2020 09.

Article en En | MEDLINE | ID: mdl-32590358

Asunto(s)

Neoplasia Endocrina Múltiple Tipo 1/tratamiento farmacológico; Tumores Neuroendocrinos/tratamiento farmacológico; Femenino; Humanos; Masculino

Palabras clave

MEN1; endocrine neoplasia; neuroendocrine neoplasms; preclinical studies

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tumores Neuroendocrinos / Neoplasia Endocrina Múltiple Tipo 1 Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Endocr Relat Cancer Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google